Live Chat ×
Skip to main content

SC29 - Pathology in the Era of Genomic Medicine: New Frontiers and New Challenges

This item is expired.

Evaluated by: Laura W. Lamps, M.D., UAMS Health, July 8, 2016
Original release date: July 8, 2016
Access to this course expires on: March 1, 2019
CME/SAMs 3.0
Course Description
The promise of personalized medicine has been upon us for years. This course addresses the impact of genomic medicine on patient management, and redefining the role of the pathologist from a diagnostic specialist to a decision maker in the era of personalized medicine. This course is designed for practicing pathologists, molecular lab directors, basic scientists, and pathologists-in-training. The course will be in the form of four presentations that will discuss the impact of genomics on patient care, the phases of implementation and challenges that face the transition into precision medicine, including ethical, QC and training issues. We focus on the real-life examples of molecular testing.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

  1. The concept of genomic medicine and its scope of applications and impact on cancer management
  2. The basic principles of the most commonly used tools for molecular profiling and their applications, advantages and limitations,
  3. Challenges that need to be addressed in moving into personalized medicine.

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 3  AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 3 SAM credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: George M. Yousef, M.D. Ph.D., University of Toronto, Canada and George Netto, M.D., Johns Hopkins University School of Medicine, Baltimore, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by
clicking here.

Not A Member? Click Here